Thomas Strüngmann

Last updated

Thomas Strüngmann (born 1950) founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. In 2005, he and his brother Andreas sold Hexal for $6.7B. [1] They earned $8B on their stake in BioNTech SE, the German company developing the Pfizer vaccine. [2] They own approximately 50% of the company as well as significant ownership in 4SC and Immatics. [3] He currently has the largest health-care earned fortune with his brother. [4]

Contents

The brothers operate out of a family office, Athos Service. [1]

See also

Related Research Articles

Pfizer American multinational pharmaceutical corporation

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The company was established in 1849 in New York by two German immigrants, Charles Pfizer (1824-1906) and his cousin Charles F. Erhart (1821-1891).

Jeff Bezos American engineer and entrepreneur, founder of Amazon.com, Inc.

Jeffrey Preston Bezos is an American entrepreneur, media proprietor, investor, and computer engineer. He is the founder and executive chairman of Amazon, where he previously served as the chairman, president, and CEO. With a net worth of almost $200.1 billion as of September 2021, he is either the wealthiest or second-wealthiest person in the world according to both Forbes and Bloomberg's Billionaires Index.

Johnson & Johnson U.S. multinational medical manufacturer

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

AstraZeneca British-Swedish pharmaceutical company

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It has been involved in developing the Oxford-AstraZeneca COVID-19 vaccine.

Kenneth C. Griffin American billionaire hedge fund manager (born 1968)

Kenneth Cordele Griffin is an American hedge fund manager, entrepreneur and investor. He is the founder, chief executive officer, co-chief investment officer, and 85% owner of Citadel LLC, a multinational hedge fund and the largest market maker in the U.S.

Ray Dalio American billionaire hedge fund manager

Raymond Thomas Dalio is an American billionaire investor and hedge fund manager, who has served as co-chief investment officer of the world's largest hedge fund, Bridgewater Associates, since 1985. He founded Bridgewater in 1975 in New York. Within ten years, it was infused with a $5 million investment from the World Bank's retirement fund. Dalio is regarded as one of the greatest innovators in the finance world, having popularized many commonly used practices, such as risk parity, currency overlay, portable alpha and global inflation-indexed bond management.

Dustin Moskovitz American billionaire and entrepreneur

Dustin Aaron Moskovitz is an American Internet entrepreneur who co-founded Facebook with Mark Zuckerberg, Eduardo Saverin, Andrew McCollum and Chris Hughes. In 2008, he left Facebook to co-found Asana with Justin Rosenstein. In March 2011, Forbes reported Moskovitz to be the youngest self-made billionaire in history, on the basis of his 2.34% share in Facebook. As of September 2021, his net worth is estimated at US$24.4 billion.

Sinovac Biotech Ltd. is a Chinese biopharmaceutical company that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company is based in Haidian District, Beijing in China. The company is listed on the NASDAQ but the exchange halted Sinovac's trading in February 2019 due to a proxy fight.

China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

Nathan "Natie" Kirsh is a Swazi billionaire businessman. He heads the Kirsh Group, which holds a majority stake in New York cash and carry operation Jetro Holdings, owner of Restaurant Depot and Jetro Cash & Carry. The Group also holds equity and investments in Australia, Eswatini, the UK, the US, and Israel.

<i>The Worlds Billionaires</i> Annual ranking by net worth by Forbes magazine

The World's Billionaires is an annual ranking by documented net worth of the wealthiest billionaires in the world, compiled and published in March annually by the American business magazine Forbes. The list was first published in March 1987. The total net worth of each individual on the list is estimated and is cited in United States dollars, based on their documented assets and accounting for debt and other factors. Royalty and dictators whose wealth comes from their positions are excluded from these lists. This ranking is an index of the wealthiest documented individuals, excluding any ranking of those with wealth that is not able to be completely ascertained.

Moderna American biotechnology company

Moderna, Inc is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on vaccine technologies based on messenger RNA (mRNA). Moderna's vaccine platform inserts synthetic nucleoside-modified messenger RNA (modRNA) into human cells using a coating of lipid nanoparticles. This mRNA then reprograms the cells to prompt immune responses. Moderna develops mRNA therapeutic vaccines that are delivered in lipid nanoparticles, using mRNA with pseudouridine nucleosides. Candidates are designed to have improved folding and translation efficiency via insertional mutagenesis.

Adar Poonawalla Indian businessman

Adar Poonawalla is the chief executive officer (CEO) of Serum Institute of India. Founded in 1966 by his father, Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced.

Playrix Russian game developer and publisher

Playrix Holding Ltd., also known as Playrix Entertainment and Playrix Games, is a developer of free-to-play mobile games behind titles such as Fishdom and Gardenscapes. The company was founded by Dmitry Bukhman and Igor Bukhman in 2004 in Vologda, Russia. Playrix has been headquartered in Dublin since 2013.

James Monsees American businessman

James Monsees is an American businessman, and the co-founder and chief product officer of Juul Labs, an electronic cigarette company.

Eric S. Yuan is a Chinese-American billionaire businessman, engineer, and the CEO and founder of Zoom Video Communications, of which he owns 22%.

COVID-19 vaccine Vaccine designed to provide acquired immunity against SARS-CoV-2

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19). Prior to the COVID‑19 pandemic, an established body of knowledge existed about the structure and function of coronaviruses causing diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). This knowledge accelerated the development of various vaccine platforms during early 2020. The initial focus of SARS-CoV-2 vaccines was on preventing symptomatic, often severe illness. On 10 January 2020, the SARS-CoV-2 genetic sequence data was shared through GISAID, and by 19 March, the global pharmaceutical industry announced a major commitment to address COVID-19. The COVID‑19 vaccines are widely credited for their role in reducing the spread, severity, and death caused by COVID-19.

Operation Warp Speed American public–private partnership designed to accelerate COVID-19 vaccine development

Operation Warp Speed (OWS) was a public–private partnership initiated by the United States government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation Warp Speed was on April 29, 2020, and the program was officially announced on May 15, 2020. It was headed by Moncef Slaoui from May 2020 to January 2021 and by David A. Kessler from January to February 2021. At the end of February 2021, Operation Warp Speed was transferred into the responsibilities of the White House COVID-19 Response Team.

Deployment of COVID-19 vaccines Distribution and administration of COVID-19 vaccinations

As of 1 September 2021, 5.34 billion COVID-19 vaccine doses had been administered worldwide, with 39.6 per cent of the global population having received at least one dose. While 40.5 million vaccines were then being administered daily, only 1.8 per cent of people in low-income countries had received at least a first vaccine by September 2021, according to official reports from national health agencies, which is collated by Our World in Data.

References

  1. 1 2 Manskar, Noah (2020-11-13). "COVID-19 vaccine hopes have made these twins $8 billion richer". New York Post. Retrieved 2021-07-13.
  2. Stupples, Benjamin (November 13, 2020). "Brothers Build $22 Billion Fortune on Hope for Covid-19 Vaccine". Bloomberg.
  3. Manskar, Noah (2020-11-13). "COVID-19 vaccine hopes have made these twins $8 billion richer". New York Post. Retrieved 2021-07-13.
  4. "Bloomberg Billionaires Index". Bloomberg.